Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Preferentially expressed antigen in melanoma pseudogene (ENSG00000231590) is a genomic sequence in humans that closely resembles the protein-coding PRAME gene but does not encode a functional protein. Pseudogenes typically arise following gene duplications or retrotransposition events and are considered nonfunctional due to mutations, lack of regulatory elements, or incomplete sequence. There is no evidence that this pseudogene is expressed, codes for a protein, or has a direct biological or disease role. Its existence is of potential interest for genomic evolution or bioinformatics, but not for drug development, biomarker applications, or basic biology at this time.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Preferentially expressed antigen in melanoma pseudogene.